Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 1 ... enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional...
2009 OCT 19 ... placebo-controlled Phase 3 trial (CLASSIC I) comparing clofarabine in combination with cytarabine to cytarabine alone in relapsed and refractory adult ...
2009 NOV 2 ... a randomized, placebo-controlled phase 3 trial comparing Clolar in combination with cytarabine to cytarabine alone in relapsed and refractory adult ...
2009 OCT 12 ... were treated with 2 cladribine-based regimens: CLAG (cladribine [5 mg/m(2) days 1-5], cytarabine [2 g/m(2) days 1-5] and granulocyte colony-stimulating factor [G-CSF; 300 mu g ...
2009 OCT 19 ... application sequence independent synergistic antileukemic effects in combination with cytarabine and daunorubicin. Strong synergistic antiproliferative and proapoptotic effects were ...
2009 OCT 12 ... woman with chronic myeloid leukemia who received treatment with alpha-interferon and cytarabine over 5 years. Her chemotherapy was then switched to imatinib 400 mg/day because she ...
2009 NOV 23 ... of cytotoxic chemotherapy. It is more frequently associated with 5-FU, capecitabine, and cytarabine. This article reports on the case of a 55-year-old black man with metastatic colorectal ...
2009 OCT 12 ... myeloid leukemia (AML) secured, he began induction chemotherapy with idarubicin and cytarabine. Two weeks later, he died of fungal septicemia and multiorgan failure. Through a ...
2009 NOV 23 ... diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin,' are discussed in a new report. According to recent research from the ...
2009 OCT 12 ... published their study in Apoptosis (Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells. Apoptosis, ...
2009 OCT 19 ... vincristine, adriamycin, dexamethasone) plus imatinib/dasatinib or idarubicin plus cytarabine (Ara-C); 2 did not respond, 1 had CCyR, and 1 short-lasting complete molecular response ...
2009 OCT 19 ... and who were 60 to 83 years of age ( median, 67) were randomly assigned to receive cytarabine, at a dose of 200 mg per square meter by continuous infusion for 7 days, plus ...
2009 NOV 16 ... and intranuclear mobility in human carcinoma cells A549 and UO31 after treatment with cytarabine, doxorubicin, and mercaptopurine," investigators in the United States report. ...
2009 NOV 9 ... the highest planned dose of 350 mg/m(2) in combination with idarubicin and high-dose cytarabine reinduction chemotherapy. Correlative studies were conducted to determine the effects of ...
2009 NOV 23 ... He was included in the HOVON-51 study (www.hovon.nl) and received two cycles of cytarabine 200 mg/m(2) for 7 days and imatinib 800 mg, q.d., continuously. Swiftly, he attained a ...
2009 NOV 2 ... with AML in second remission. Step 1 consisted of consolidation chemotherapy using cytarabine 2000 mg/m(2) i.v. every 12 h for 4 days plus etoposide 40 mg/kg total dose by continuous ...
2009 NOV 9 ... Results from REVEAL-1 and our ongoing Phase 1b/2 trial of voreloxin in combination with cytarabine in relapsed/refractory AML will contribute greatly to our clinical development strategy ...
2009 NOV 23 ... in the Company's ongoing Phase 2 clinical study of voreloxin in combination with cytarabine in relapsed or refractory AML. Studies also provide evidence of voreloxin's synergistic ...
2009 NOV 16 ... standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML. "This designation recognizes the acute need ...
